Cita APA

Kong, A., Rea, D., Ahmed, S., Beck, J. T., López López, R., Biganzoli, L., . . . Lee, S. (2016). Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen.

Citación estilo Chicago

Kong, Anthony, et al. Phase 1B/2 Study of the HSP90 Inhibitor AUY922 Plus Trastuzumab in Metastatic HER2-positive Breast Cancer Patients Who Have Progressed On Trastuzumab-based Regimen. 2016.

Cita MLA

Kong, Anthony, et al. Phase 1B/2 Study of the HSP90 Inhibitor AUY922 Plus Trastuzumab in Metastatic HER2-positive Breast Cancer Patients Who Have Progressed On Trastuzumab-based Regimen. 2016.